| Stock Code: 200771 Stock ID: Hangqilun B | | Announcement No.:2025-86 | | | --- | --- | --- | --- | | Hangzhou Turbine Power Group Co., Ltd. | | | | | The Semi-Annual Financial Report 2025 | | | | | （Stock Code：200771） August 2025 | | | | | | | | The Semi-Annual Financial Report 2025 | | Financial Report | | | | | I. Auditors' Report | | | | | Whether the semi-annual financial report had been audited? | | | | | □Yes ?No | | | | | The Semi-annual Financial Report is not audited. | | | | | II. The Financial ...

Financial Overview - The company did not undergo an audit for its semi-annual financial report [1] - Total assets decreased from 4,694,759,462.62 yuan to 4,597,160,999.04 yuan [1][2] - Total liabilities decreased from 2,210,982,759.52 yuan to 2,054,017,572.60 yuan [2][3] - Total equity increased from 2,483,776,703.10 yuan to 2,543,143,426.44 yuan [2][3] Asset Composition - Current assets decreased from 3,560,586,795.85 yuan to 3,430,526,535.51 yuan [1] - Cash and cash equivalents decreased from 904,773,950.94 yuan to 685,108,129.82 yuan [1] - Inventory increased from 733,218,479.77 yuan to 785,805,070.73 yuan [1] Liabilities Breakdown - Current liabilities decreased from 2,141,672,477.86 yuan to 1,993,300,053.64 yuan [2] - Short-term borrowings decreased from 87,729,472.40 yuan to 74,647,817.95 yuan [1][2] - Accounts payable decreased from 867,757,474.48 yuan to 779,421,312.59 yuan [1][2] Equity Changes - Retained earnings increased from 645,565,196.76 yuan to 687,013,030.08 yuan [2] - Other comprehensive income increased from 189,767,216.78 yuan to 207,429,923.48 yuan [2] Revenue and Profitability - Total operating revenue for the first half of 2025 was 795,485,831.73 yuan, up from 689,187,321.59 yuan in the same period of 2024 [3][4] - Total operating costs increased from 678,066,758.25 yuan to 778,484,426.97 yuan [3][4] - Net profit for the first half of 2025 was 38,560,603.08 yuan, compared to 19,703,942.02 yuan in the first half of 2024 [4] Cash Flow Analysis - Net cash flow from operating activities was -136,133,325.49 yuan for the first half of 2025, compared to -49,163,430.65 yuan in the same period of 2024 [5] - Cash flow from investing activities was -40,549,600.60 yuan for the first half of 2025, compared to -20,290,896.99 yuan in the same period of 2024 [5][6] - Cash flow from financing activities was -23,597,979.87 yuan for the first half of 2025, compared to -116,102,152.03 yuan in the same period of 2024 [5][6]

Company Overview - Guangdong Aofei Data Technology Co., Ltd. was established on August 4, 2014, with a registered capital of 114.2 million RMB after a capital increase of 53.25 million RMB through the issuance of shares at 37.50 RMB each [1] - The company underwent several capital increases and stock issuances, including a non-public offering of 816,500 shares at 84.28 RMB each in 2016, raising 68.81 million RMB, and a public offering of 16.32 million shares in 2018, increasing the registered capital to 65.26 million RMB [1] - As of April 4, 2023, the company issued 103.65 million shares to 11 specific investors, raising the registered capital to 794.64 million RMB [1] Financial Reporting Basis - The financial statements are prepared based on the going concern assumption, following the accounting standards and guidelines set by the relevant authorities [1] - The company has assessed its ability to continue as a going concern and found no issues affecting this assumption [1] Important Accounting Policies - The company adheres to significant accounting policies and estimates as per the enterprise accounting standards, ensuring that the financial statements reflect a true and complete picture of its financial status, operating results, and cash flows [1][2] - The company recognizes and measures transactions based on actual occurrences, ensuring compliance with the disclosure rules set by the China Securities Regulatory Commission [1] Capital Changes - The company has executed multiple capital increases through stock issuances and capital reserves, including a significant increase in registered capital to 1.99 billion RMB after a capital reserve conversion [1] - The company issued convertible bonds in December 2021, which will convert into approximately 23.99 million shares by December 31, 2024, further increasing the registered capital [1] Financial Instruments - The company classifies financial instruments based on their characteristics and management objectives, including those measured at amortized cost and those measured at fair value [19][20] - Financial assets are assessed for impairment based on expected credit losses, ensuring that potential losses are recognized in a timely manner [23]

Company Overview - Fujian Guangshentang Pharmaceutical Co., Ltd. was established as a joint-stock company from the transformation of Fujian Guangshentang Pharmaceutical Co., Ltd. [1] - The company is located in Fujian Province, with its registered capital and paid-in capital both amounting to 159.267 million RMB as of December 31, 2024 [3]. Business Nature and Activities - The company operates in the pharmaceutical manufacturing industry, with a business scope that includes drug production, wholesale, retail, food sales, health food production, and drug import/export [3]. - The company has 13 subsidiaries included in its consolidated financial statements, with an increase of 2 subsidiaries compared to the previous period [3]. Financial Reporting - The financial statements were approved by the board of directors on April 16, 2025 [4]. - The company prepares its financial statements based on actual transactions and events, adhering to the accounting standards set by the Ministry of Finance [4]. Financial Condition - The company has experienced continuous losses over the past three years due to significant R&D investments, with a consolidated asset-liability ratio of 72.42% as of December 31, 2024 [4]. - The company has a total of 300 million RMB in borrowings, with available cash of 143 million RMB and unused credit lines of 125 million RMB, indicating a strategy to maintain liquidity [4]. Capital Structure - The company issued 17.5 million A-shares in 2015, with 3.5 million shares being transferred and 14 million new shares issued [1]. - In 2021, the company issued 18.777 million shares to specific investors, with the new shares listed on July 9, 2021 [1]. Stock Option Plan - The company approved a stock option incentive plan, allowing 22 eligible participants to exercise 798,000 stock options at a price of 31.23 RMB per share, with a total exercise amount of approximately 15.3 million RMB [2].